Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 78.40M | £ 273.60M | £ 178.30M | £ 348.80M | £ 134.00M |
Total Assets | £ 2.03B | £ 1.67B | £ 1.47B | £ 1.35B | £ 1.14B |
Total Debt | £ 156.00M | £ 776.80M | £ 109.20M | £ 764.70M | £ 78.90M |
Net Debt | £ 77.60M | £ 503.20M | £ -69.10M | £ 415.90M | £ -55.10M |
Total Liabilities | £ 1.74B | £ 1.46B | £ 1.26B | £ 1.15B | £ 875.30M |
Stockholders Equity | £ 294.70M | £ 202.60M | £ 207.60M | £ 208.20M | £ 261.70M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |